These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 8722521

  • 1. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
    Diller LH.
    Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521
    [No Abstract] [Full Text] [Related]

  • 2. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO, Liliemark J, Klintberg K, von Knorring AL.
    Nord J Psychiatry; 2009 Nov 30; 63(6):508-16. PubMed ID: 19958258
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep 30; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. What's all the fuss about Ritalin?
    Accardo P, Blondis TA.
    J Pediatr; 2001 Jan 30; 138(1):6-9. PubMed ID: 11148505
    [No Abstract] [Full Text] [Related]

  • 12. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 30; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 30; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 15. Drugs and children.
    Pinkham JR.
    ASDC J Dent Child; 2002 Jan 30; 69(1):10. PubMed ID: 12119805
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M, Uekermann J, Wiltfang J, Kis B.
    Clin Neuropharmacol; 2010 Jul 30; 33(4):204-6. PubMed ID: 20571380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.